Hypoglycemic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice

被引：0
|
作者：
Inoue, T
Yoshitomi, H
Kasai, S
Hihara, T
Matsuura, F
Shinoda, M
Saeki, T
Tanaka, I
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A129 / A129
页数：1
相关论文
共 50 条
  • [21] Effects of tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist on atherosclerosis and visceral fat in low density lipoprotein receptor deficient mice
    Chira, Ebele C.
    McMillen, Timothy
    Wang, Shari
    Chait, Alan
    DIABETES, 2006, 55 : A153 - A153
  • [22] Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy
    Deng, Guotao
    Moran, Elizabeth P.
    Cheng, Rui
    Matlock, Greg
    Zhou, Kelu
    Moran, David
    Chen, Danyang
    Yu, Qiang
    Ma, Jian-Xing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (12) : 5030 - 5042
  • [23] Glycemic and Lipid Effects and Cardiovascular Safety of a Novel Dual Peroxisome Proliferator-Activated Receptor α/γ Agonist
    Lincoff, A. Michael
    Henry, Robert R.
    Mudaliar, Sunder
    Chognot, Cathy
    Rabbia, Michael
    Herz, Matthias
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A207 - A207
  • [24] A novel peroxisome proliferator-activated receptor α/γ dual agonist demonstrates favorable effects on lipid homeostasis
    Guo, Q
    Sahoo, SP
    Wang, PR
    Milot, DP
    Ippolito, MC
    Wu, MS
    Baffic, J
    Biswas, C
    Hernandez, M
    Lam, MH
    Sharma, N
    Han, W
    Kelly, LJ
    Macnaul, KL
    Zhou, GC
    Desai, R
    Heck, JV
    Doebber, TW
    Berger, JP
    Moller, DE
    Sparrow, CP
    Chao, YS
    Wright, SD
    ENDOCRINOLOGY, 2004, 145 (04) : 1640 - 1648
  • [25] Peroxisome Proliferator-Activated Receptor Alpha (PPARα), Beta (PPARβ), and Gamma (PPARγ) Expression in Human Fetal Tissues
    Abbott, B. D.
    Wood, C. R.
    Watkins, A. M.
    Das, K. P.
    Lau, C. S.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2010, 88 (05) : 352 - 352
  • [26] Cyclopia intermedia (Honeybush) Induces Uncoupling Protein 1 and Peroxisome Proliferator-Activated Receptor Alpha Expression in Obese Diabetic Female db/db Mice
    Jack, Babalwa Unice
    Ramharack, Pritika
    Malherbe, Christiaan
    Gabuza, Kwazi
    Joubert, Elizabeth
    Pheiffer, Carmen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [27] Pterostilbene as a new natural product agonist for the peroxisome proliferator-activated receptor alpha (PPARα) isoform
    Rimando, AM
    Nagmani, R
    Feller, DR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U63 - U63
  • [28] Peroxisome Proliferator-Activated Receptor Pan Agonist, YNHM 16, Ameliorates Renal and Adipose Tissue Inflammation without Deteriorating Fatty Liver in db/db Mice
    Hatanaka, Takashi
    Ogawa, Daisuke
    Terami, Naoto
    Tachibana, Hiromi
    Nakatsuka, Atsuko
    Eguchi, Jun
    Wada, Jun
    DIABETES, 2017, 66 : A336 - A336
  • [29] Inhibition of Aldose Reductase Activates Hepatic Peroxisome Proliferator-Activated Receptor-α and Ameliorates Hepatosteatosis in Diabetic db/db Mice
    Qiu, Longxin
    Lin, Jianhui
    Xu, Fangui
    Gao, Yuehong
    Zhang, Cuilin
    Liu, Ying
    Luo, Yu
    Yang, James Y.
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [30] Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice
    Chira, Ebele C.
    McMillen, Timothy S.
    Wang, Shari
    Haw, Antonio, III
    O'Brien, Kevin D.
    Wight, Thomas N.
    Chait, Alan
    ATHEROSCLEROSIS, 2007, 195 (01) : 100 - 109
12345